Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jun 27, 2023; 15(6): 1232-1239
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1232
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1232
Figure 1 Pseudoaneurysm bleeding after atezolizumab–bevacizumab treatment.
A: Magnetic resonance imaging (MRI) of the abdomen revealed multifocal enhancing hepatocellular carcinoma lesions in the liver (white arrows); B: After transcatheter arterial chemoembolization and lenvatinib treatment, MRI showed disease progression (white arrows); C and D: After three cycles of atezolizumab plus bevacizumab, MRI showed progressive disease (white arrows) but no remarkable gastroesophageal varices (white arrowhead).
- Citation: Pang FW, Chen B, Peng DT, He J, Zhao WC, Chen TT, Xie ZG, Deng HH. Massive bleeding from a gastric artery pseudoaneurysm in hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A case report. World J Gastrointest Surg 2023; 15(6): 1232-1239
- URL: https://www.wjgnet.com/1948-9366/full/v15/i6/1232.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i6.1232